Evofem Reports Fourth Consecutive Year of Net Sales Growth
Provided By PR Newswire
Last update: Mar 24, 2025
-- 2024 Net Sales Increased 6% to $19.4 Million --
-- Total Operating Expense Reduced 27% from 2023 Levels,
Excluding Non-cash Amortization Expense --
-- Sales and Marketing Expense as a Percentage of Net Sales was 47% for 2024 and
31% for the Fourth Quarter, the Most Favorable Ratios since the PHEXXI Launch --
